share_log

Aptevo Therapeutics Q1 EPS $(9.95) Beats $(12.84) Estimate

Aptevo Therapeutics Q1 EPS $(9.95) Beats $(12.84) Estimate

Aptevo Therapeutics第一季度每股收益美元(9.95美元)超过预期(12.84美元)
Benzinga ·  05/08 08:34

Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(9.95) per share which beat the analyst consensus estimate of $(12.84) by 22.51 percent. This is a 76.92 percent increase over losses of $(43.12) per share from the same period last year.

Aptevo Therapeutics(纳斯达克股票代码:APVO)公布的季度亏损为每股9.95美元(9.95美元),比分析师普遍预期的12.84美元(12.84美元)高出22.51%。这比去年同期每股亏损43.12美元(43.12美元)增长了76.92%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发